Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-05-16

AUTHORS

Varsha Tulpule, Gareth J. Morrison, Mary Falcone, David I. Quinn, Amir Goldkorn

ABSTRACT

Purpose of ReviewThe field of liquid biopsies is constantly evolving through novel technologies. This review outlines current data on liquid biopsies and application to clinical management of metastatic prostate cancer.Recent FindingsTo date, there are three platforms with FDA approval for use in the setting of metastatic prostate cancer and others which have been clinically validated. There is substantial evidence supporting the use of circulating tumor cell (CTC) enumeration to guide prognosis in metastatic castration-resistant prostate cancer (mCRPC). Additional evidence supports targeted sequencing of CTC and cell-free DNA (cfDNA) to guide androgren-directed therapy, identify candidates for treatment with PARP inhibitors, and monitor development of resistance.SummaryAs a real-time and minimally invasive approach, utilization of liquid biopsies has the potential to drastically impact the treatment of metastatic prostate cancer and improve overall survival. With further clinical validation, additional liquid biopsy is likely to enter standard clinical practice. More... »

PAGES

1-12

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11912-022-01278-0

DOI

http://dx.doi.org/10.1007/s11912-022-01278-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1147900649

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35575959


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tulpule", 
        "givenName": "Varsha", 
        "id": "sg:person.010664314747.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010664314747.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morrison", 
        "givenName": "Gareth J.", 
        "id": "sg:person.012102513474.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012102513474.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Falcone", 
        "givenName": "Mary", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA", 
            "Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quinn", 
        "givenName": "David I.", 
        "id": "sg:person.01013134010.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA", 
            "Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA", 
            "Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldkorn", 
        "givenName": "Amir", 
        "id": "sg:person.0741147700.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741147700.94"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s13148-021-01155-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1140708512", 
          "https://doi.org/10.1186/s13148-021-01155-w"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41591-020-0915-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1128096281", 
          "https://doi.org/10.1038/s41591-020-0915-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc4016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046543135", 
          "https://doi.org/10.1038/nrc4016"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature14347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029125143", 
          "https://doi.org/10.1038/nature14347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/srep17533", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031824518", 
          "https://doi.org/10.1038/srep17533"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt.3520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042966935", 
          "https://doi.org/10.1038/nbt.3520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41391-020-0215-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1125090591", 
          "https://doi.org/10.1038/s41391-020-0215-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41588-020-0648-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1129306908", 
          "https://doi.org/10.1038/s41588-020-0648-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nmeth898", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028618204", 
          "https://doi.org/10.1038/nmeth898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41467-018-05793-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106100334", 
          "https://doi.org/10.1038/s41467-018-05793-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11523-020-00720-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1128221654", 
          "https://doi.org/10.1007/s11523-020-00720-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.1789", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051933380", 
          "https://doi.org/10.1038/nm.1789"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-05-16", 
    "datePublishedReg": "2022-05-16", 
    "description": "Purpose of ReviewThe field of liquid biopsies is constantly evolving through novel technologies. This review outlines current data on liquid biopsies and application to clinical management of metastatic prostate cancer.Recent FindingsTo date, there are three platforms with FDA approval for use in the setting of metastatic prostate cancer and others which have been clinically validated. There is substantial evidence supporting the use of circulating tumor cell (CTC) enumeration to guide prognosis in metastatic castration-resistant prostate cancer (mCRPC). Additional evidence supports targeted sequencing of CTC and cell-free DNA (cfDNA) to guide androgren-directed therapy, identify candidates for treatment with PARP inhibitors, and monitor development of resistance.SummaryAs a real-time and minimally invasive approach, utilization of liquid biopsies has the potential to drastically impact the treatment of metastatic prostate cancer and improve overall survival. With further clinical validation, additional liquid biopsy is likely to enter standard clinical practice.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11912-022-01278-0", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.9615196", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1021174", 
        "issn": [
          "1523-3790", 
          "1534-6269"
        ], 
        "name": "Current Oncology Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "metastatic prostate cancer", 
      "metastatic castration-resistant prostate cancer", 
      "prostate cancer", 
      "cell-free DNA", 
      "liquid biopsy", 
      "clinical management", 
      "castration-resistant prostate cancer", 
      "tumor cell (CTC) enumeration", 
      "Recent FindingsTo date", 
      "standard clinical practice", 
      "further clinical validation", 
      "overall survival", 
      "development of resistance", 
      "invasive approach", 
      "clinical practice", 
      "biopsy", 
      "FDA approval", 
      "PARP inhibitors", 
      "cancer", 
      "clinical validation", 
      "ReviewThe field", 
      "substantial evidence", 
      "current data", 
      "cell enumeration", 
      "treatment", 
      "additional evidence", 
      "prognosis", 
      "therapy", 
      "evidence", 
      "survival", 
      "management", 
      "CTCs", 
      "SummaryAs", 
      "inhibitors", 
      "approval", 
      "review", 
      "setting", 
      "use", 
      "sequencing", 
      "novel technology", 
      "date", 
      "resistance", 
      "DNA", 
      "practice", 
      "candidates", 
      "purpose", 
      "data", 
      "development", 
      "utilization", 
      "potential", 
      "validation", 
      "enumeration", 
      "approach", 
      "platform", 
      "integration", 
      "applications", 
      "technology", 
      "field"
    ], 
    "name": "Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer", 
    "pagination": "1-12", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1147900649"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11912-022-01278-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35575959"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11912-022-01278-0", 
      "https://app.dimensions.ai/details/publication/pub.1147900649"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_948.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11912-022-01278-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11912-022-01278-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11912-022-01278-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11912-022-01278-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11912-022-01278-0'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      93 URIs      73 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11912-022-01278-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N9bd6590973b34d13a4bdb9ff95fd8936
4 schema:citation sg:pub.10.1007/s11523-020-00720-2
5 sg:pub.10.1038/nature14347
6 sg:pub.10.1038/nbt.3520
7 sg:pub.10.1038/nm.1789
8 sg:pub.10.1038/nmeth898
9 sg:pub.10.1038/nrc4016
10 sg:pub.10.1038/s41391-020-0215-5
11 sg:pub.10.1038/s41467-018-05793-2
12 sg:pub.10.1038/s41588-020-0648-8
13 sg:pub.10.1038/s41591-020-0915-3
14 sg:pub.10.1038/srep17533
15 sg:pub.10.1186/s13148-021-01155-w
16 schema:datePublished 2022-05-16
17 schema:datePublishedReg 2022-05-16
18 schema:description Purpose of ReviewThe field of liquid biopsies is constantly evolving through novel technologies. This review outlines current data on liquid biopsies and application to clinical management of metastatic prostate cancer.Recent FindingsTo date, there are three platforms with FDA approval for use in the setting of metastatic prostate cancer and others which have been clinically validated. There is substantial evidence supporting the use of circulating tumor cell (CTC) enumeration to guide prognosis in metastatic castration-resistant prostate cancer (mCRPC). Additional evidence supports targeted sequencing of CTC and cell-free DNA (cfDNA) to guide androgren-directed therapy, identify candidates for treatment with PARP inhibitors, and monitor development of resistance.SummaryAs a real-time and minimally invasive approach, utilization of liquid biopsies has the potential to drastically impact the treatment of metastatic prostate cancer and improve overall survival. With further clinical validation, additional liquid biopsy is likely to enter standard clinical practice.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf sg:journal.1021174
22 schema:keywords CTCs
23 DNA
24 FDA approval
25 PARP inhibitors
26 Recent FindingsTo date
27 ReviewThe field
28 SummaryAs
29 additional evidence
30 applications
31 approach
32 approval
33 biopsy
34 cancer
35 candidates
36 castration-resistant prostate cancer
37 cell enumeration
38 cell-free DNA
39 clinical management
40 clinical practice
41 clinical validation
42 current data
43 data
44 date
45 development
46 development of resistance
47 enumeration
48 evidence
49 field
50 further clinical validation
51 inhibitors
52 integration
53 invasive approach
54 liquid biopsy
55 management
56 metastatic castration-resistant prostate cancer
57 metastatic prostate cancer
58 novel technology
59 overall survival
60 platform
61 potential
62 practice
63 prognosis
64 prostate cancer
65 purpose
66 resistance
67 review
68 sequencing
69 setting
70 standard clinical practice
71 substantial evidence
72 survival
73 technology
74 therapy
75 treatment
76 tumor cell (CTC) enumeration
77 use
78 utilization
79 validation
80 schema:name Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer
81 schema:pagination 1-12
82 schema:productId N0d346c6c8d534709a33e9d425fbd11a3
83 N1d10d099d9684e3e94319402bf5ac812
84 N2100da07a61d4c1ab87d6d3f08a4f272
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1147900649
86 https://doi.org/10.1007/s11912-022-01278-0
87 schema:sdDatePublished 2022-09-02T16:08
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher N75052c5dfb174380a41de1b213136bc7
90 schema:url https://doi.org/10.1007/s11912-022-01278-0
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N0d346c6c8d534709a33e9d425fbd11a3 schema:name dimensions_id
95 schema:value pub.1147900649
96 rdf:type schema:PropertyValue
97 N0f8775c4cf44465cb768238266f37531 schema:affiliation grid-institutes:grid.42505.36
98 schema:familyName Falcone
99 schema:givenName Mary
100 rdf:type schema:Person
101 N1d10d099d9684e3e94319402bf5ac812 schema:name doi
102 schema:value 10.1007/s11912-022-01278-0
103 rdf:type schema:PropertyValue
104 N2100da07a61d4c1ab87d6d3f08a4f272 schema:name pubmed_id
105 schema:value 35575959
106 rdf:type schema:PropertyValue
107 N6dd9cffd0d674b6896b01a878e2bdffe rdf:first sg:person.012102513474.31
108 rdf:rest N9c744b7187bc42c78453a4486497bd30
109 N75052c5dfb174380a41de1b213136bc7 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N9bd6590973b34d13a4bdb9ff95fd8936 rdf:first sg:person.010664314747.80
112 rdf:rest N6dd9cffd0d674b6896b01a878e2bdffe
113 N9c744b7187bc42c78453a4486497bd30 rdf:first N0f8775c4cf44465cb768238266f37531
114 rdf:rest Ne8db8cc7ecf94ff18ebbbaf0a2d0db4b
115 Ne8db8cc7ecf94ff18ebbbaf0a2d0db4b rdf:first sg:person.01013134010.15
116 rdf:rest Nee81639fd59b4662bb2774f7f89c540c
117 Nee81639fd59b4662bb2774f7f89c540c rdf:first sg:person.0741147700.94
118 rdf:rest rdf:nil
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
123 schema:name Oncology and Carcinogenesis
124 rdf:type schema:DefinedTerm
125 sg:grant.9615196 http://pending.schema.org/fundedItem sg:pub.10.1007/s11912-022-01278-0
126 rdf:type schema:MonetaryGrant
127 sg:journal.1021174 schema:issn 1523-3790
128 1534-6269
129 schema:name Current Oncology Reports
130 schema:publisher Springer Nature
131 rdf:type schema:Periodical
132 sg:person.01013134010.15 schema:affiliation grid-institutes:grid.42505.36
133 schema:familyName Quinn
134 schema:givenName David I.
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15
136 rdf:type schema:Person
137 sg:person.010664314747.80 schema:affiliation grid-institutes:grid.42505.36
138 schema:familyName Tulpule
139 schema:givenName Varsha
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010664314747.80
141 rdf:type schema:Person
142 sg:person.012102513474.31 schema:affiliation grid-institutes:grid.42505.36
143 schema:familyName Morrison
144 schema:givenName Gareth J.
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012102513474.31
146 rdf:type schema:Person
147 sg:person.0741147700.94 schema:affiliation grid-institutes:grid.42505.36
148 schema:familyName Goldkorn
149 schema:givenName Amir
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741147700.94
151 rdf:type schema:Person
152 sg:pub.10.1007/s11523-020-00720-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128221654
153 https://doi.org/10.1007/s11523-020-00720-2
154 rdf:type schema:CreativeWork
155 sg:pub.10.1038/nature14347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029125143
156 https://doi.org/10.1038/nature14347
157 rdf:type schema:CreativeWork
158 sg:pub.10.1038/nbt.3520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042966935
159 https://doi.org/10.1038/nbt.3520
160 rdf:type schema:CreativeWork
161 sg:pub.10.1038/nm.1789 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051933380
162 https://doi.org/10.1038/nm.1789
163 rdf:type schema:CreativeWork
164 sg:pub.10.1038/nmeth898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028618204
165 https://doi.org/10.1038/nmeth898
166 rdf:type schema:CreativeWork
167 sg:pub.10.1038/nrc4016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046543135
168 https://doi.org/10.1038/nrc4016
169 rdf:type schema:CreativeWork
170 sg:pub.10.1038/s41391-020-0215-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1125090591
171 https://doi.org/10.1038/s41391-020-0215-5
172 rdf:type schema:CreativeWork
173 sg:pub.10.1038/s41467-018-05793-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106100334
174 https://doi.org/10.1038/s41467-018-05793-2
175 rdf:type schema:CreativeWork
176 sg:pub.10.1038/s41588-020-0648-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1129306908
177 https://doi.org/10.1038/s41588-020-0648-8
178 rdf:type schema:CreativeWork
179 sg:pub.10.1038/s41591-020-0915-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128096281
180 https://doi.org/10.1038/s41591-020-0915-3
181 rdf:type schema:CreativeWork
182 sg:pub.10.1038/srep17533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031824518
183 https://doi.org/10.1038/srep17533
184 rdf:type schema:CreativeWork
185 sg:pub.10.1186/s13148-021-01155-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1140708512
186 https://doi.org/10.1186/s13148-021-01155-w
187 rdf:type schema:CreativeWork
188 grid-institutes:grid.42505.36 schema:alternateName Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
189 Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
190 Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
191 schema:name Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
192 Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
193 Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...